‘Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial’ - KIds WIth wheeze trial (KIWI)

MC Utrecht0 个研究点目标入组 300 人开始时间: 2020年11月19日最近更新: 2021年11月15日

适应症

试验速览

暂无简介。

•Otherwise healthy children aged 6-24 months presenting to their primary care physician because of wheezing as confirmed by clinical examination (chest auscultation) and a baseline score of 7 or higher on a parent-reported respiratory symptom score.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 300
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Prematurity, major congenital malformations, pre-existing pulmonary disease as diagnosed by a paediatrician, continuous use of inhalation medication, physician visit because of wheezing in previous two weeks, or use of asthma medication in the previous two weeks, wheezing as a result of upper airway obstruction (i.e. laryngitis subglottica/pseudocroup) and severe illness requiring inhalation medication, prescription of antibiotics, or hospital referral; during the consultation of inclusion.

发起方

MC Utrecht